Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 25651-25700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06149910
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
N/ARecruiting
450 participants
Started: Apr 18, 2024 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05917301
Pre-operative Hypofractionated Proton Therapy
NARecruiting
40 participants
Started: Apr 18, 2024 · Completed: Dec 31, 2032
1 condition2 sponsors1 location
NCT06296251
Dietary Supplementation on Body Fat Composition
NARecruiting
150 participants
Started: Apr 18, 2024 · Completed: Feb 27, 2025
2 conditions1 sponsor1 location
NCT06345560
Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
PHASE1/PHASE2Recruiting
16 participants
Started: Apr 18, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06397963
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients with Solid Tumours
NARecruiting
18 participants
Started: Apr 18, 2024 · Completed: Apr 18, 2027
1 condition1 sponsor2 locations
NCT06382311
A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults
PHASE1/PHASE2Recruiting
996 participants
Started: Apr 18, 2024 · Completed: Jan 16, 2026
1 condition1 sponsor21 locations
NCT06261528
Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis
PHASE1Recruiting
20 participants
Started: Apr 18, 2024 · Completed: Dec 1, 2025
1 condition3 sponsors1 location
NCT06105515
Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer
NARecruiting
20 participants
Started: Apr 17, 2024 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT06030622
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
25 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05576974
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
PHASE2Recruiting
120 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06627348
Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy
NARecruiting
150 participants
Started: Apr 17, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06377566
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
PHASE2Recruiting
71 participants
Started: Apr 17, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors8 locations
NCT07011186
A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies
PHASE1/PHASE2Recruiting
138 participants
Started: Apr 17, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor21 locations
NCT06287736
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
NARecruiting
60 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT06158126
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
PHASE4Recruiting
621 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2027
3 conditions4 sponsors1 location
NCT06319378
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
PHASE2Recruiting
100 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2025
1 condition5 sponsors4 locations
NCT07212257
Creation of a Pediatric Reference Database for the Kerpape-Rennes-EMG-Based Gait Index
NARecruiting
120 participants
Started: Apr 17, 2024 · Completed: Mar 31, 2026
6 conditions1 sponsor1 location
NCT06350396
pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression
NARecruiting
270 participants
Started: Apr 17, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor5 locations
NCT06162351
A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer
PHASE2Recruiting
44 participants
Started: Apr 17, 2024 · Completed: Apr 17, 2027
2 conditions2 sponsors2 locations
NCT06394414
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
PHASE1Recruiting
162 participants
Started: Apr 17, 2024 · Completed: Apr 29, 2030
1 condition1 sponsor30 locations
NCT06548711
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
NARecruiting
84 participants
Started: Apr 17, 2024 · Completed: Jun 17, 2026
2 conditions1 sponsor1 location
NCT06443281
Pain Phenotyping in Patients with Neuropathic Pain After Spinal Cord Injury
N/ARecruiting
300 participants
Started: Apr 17, 2024 · Completed: Apr 30, 2030
4 conditions2 sponsors1 location
NCT05316688
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery
PHASE1/PHASE2Recruiting
15 participants
Started: Apr 17, 2024 · Completed: Jan 20, 2027
5 conditions2 sponsors1 location
NCT06323525
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
PHASE1/PHASE2Recruiting
30 participants
Started: Apr 17, 2024 · Completed: Apr 25, 2027
1 condition1 sponsor3 locations
NCT06405490
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
PHASE2Recruiting
30 participants
Started: Apr 17, 2024 · Completed: Dec 30, 2026
8 conditions1 sponsor1 location
NCT06211712
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion
NARecruiting
120 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06432465
tDCS to Decrease Opioid Relapse (UH3)
NARecruiting
100 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06551337
Vitamin D Replacement in Bronchiectasis
PHASE4Recruiting
104 participants
Started: Apr 17, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06331546
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NARecruiting
80 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2031
9 conditions3 sponsors2 locations
NCT06258642
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NARecruiting
39 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06431997
A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM
NARecruiting
240 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06256432
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
PHASE2Recruiting
54 participants
Started: Apr 17, 2024 · Completed: Feb 28, 2026
4 conditions1 sponsor6 locations
NCT06349993
Digital Intervention for Depression and Anxiety in Adolescents
NARecruiting
100 participants
Started: Apr 17, 2024 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT06330246
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
NARecruiting
40 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2031
8 conditions3 sponsors2 locations
NCT05465031
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
PHASE4Recruiting
600 participants
Started: Apr 17, 2024 · Completed: Feb 28, 2029
13 conditions2 sponsors4 locations
NCT06125340
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
PHASE4Recruiting
75 participants
Started: Apr 17, 2024 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT06150469
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies
NARecruiting
286 participants
Started: Apr 17, 2024 · Completed: Dec 16, 2026
1 condition1 sponsor4 locations
NCT06393296
A Study of Melatonin Concentration During Lactation
N/ARecruiting
120 participants
Started: Apr 17, 2024 · Completed: Jan 30, 2026
1 condition3 sponsors1 location
NCT06408337
Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.
PHASE1/PHASE2Recruiting
15 participants
Started: Apr 17, 2024 · Completed: Dec 17, 2028
1 condition2 sponsors1 location
NCT06238219
Management of Neuromuscular Blocking Agents and Their Antagonism
N/ARecruiting
3,000 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06295744
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
NARecruiting
50 participants
Started: Apr 17, 2024 · Completed: Feb 29, 2032
1 condition1 sponsor1 location
NCT06137378
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
PHASE2Recruiting
140 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2030
12 conditions11 sponsors9 locations
NCT06874257
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
N/ARecruiting
20 participants
Started: Apr 17, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06326294
Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NARecruiting
4,844 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06212583
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
PHASE2Recruiting
88 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2029
2 conditions2 sponsors1 location
NCT06965335
Early-Onset Colorectal Cancer: An Observational Retrospective and Prospective Multicenter Study
N/ARecruiting
20 participants
Started: Apr 17, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05972876
Graft Maturity After Blood Flow Restriction Training in ACL Reconstruction
NARecruiting
46 participants
Started: Apr 17, 2024 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06058858
Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
N/ARecruiting
250 participants
Started: Apr 17, 2024 · Completed: Apr 17, 2025
3 conditions1 sponsor3 locations
NCT06387810
Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
PHASE2Recruiting
45 participants
Started: Apr 17, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06325709
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
PHASE1/PHASE2Recruiting
10 participants
Started: Apr 17, 2024 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location